Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials - Lessons from Trial Descriptors" report has been added to ResearchAndMarkets.com's offering.
The world of clinical trials constantly evolves as new methodologies and treatments are tested. A comprehensive review of these game-changing trial descriptors has now been compiled. This resource offers a panoramic view of global clinical trial design trends that continue to shape the future of healthcare and pharmaceutical research.
This report provides an overview of various clinical trial descriptors captured in the Pharma Intelligence Center to September 2023.
Key points of interest in the analysis include:
- A precise review of varying clinical trial designs as seen in a detailed Clinical Trials Database.
- An evaluative assessment of trials, highlighting key descriptors and their evolution over time.
- In-depth trend analyses which provide indispensable intelligence for clinical trial stakeholders.
Key Topics Covered:
- Executive Summary
- Introduction
- Examining Trial Descriptors
- Key Findings
List of Tables
Table 1: Count of Clinical Trial Designs
List of Figures
Figure 1 & 2: Number of FIH clinical trials, by phase and trial start year
Figure 3: Number of FIH clinical trials, by therapy area
Figure 4: Number of FIH clinical trials, by geography
Figure 5 & 6: Number of FIH clinical trials, by sponsor
Figure 7 & 8: Number of adaptive design clinical trials, by phase and trial start year
Figure 9: Number of adaptive design clinical trials, by therapy area
Figure 10: Number of adaptive design clinical trials, by geography
Figure 11 & 12: Number of adaptive design clinical trials, by sponsor
Figure 13 & 14: Number of pivotal/registration & post marketing commitment clinical trials, by year and sponsor type
Figure 15 & 16: Number of pivotal/registration & post marketing commitment clinical trials, by therapy area
Figure 17: Number of pivotal/registration clinical trials, by geography
Figure 18: Number of approved drugs with post marketing commitments clinical trials
Figure 19 & 20: Number of pivotal/registration clinical trials, by sponsor
Figure 21 & 22: Number of post marketing commitment clinical trials, by sponsor
Figure 23 & 24: Number of basket/bucket clinical trials, by phase and trial start year
Figure 25 & 26: Number of basket/bucket clinical trials, by therapy area and indication
Figure 27: Number of basket/bucket clinical trials, by geography
Figure 28 & 29: Number of basket/bucket clinical trials, by sponsor
Figure 30 & 31: Number of umbrella clinical trials, by phase and trial start year
Figure 32 & 33: Number of umbrella clinical trials, by therapy area and indication
Figure 35 & 36: Number of umbrella clinical trials, by sponsor
For more information about this report visit https://www.researchandmarkets.com/r/hzv0c5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
